Leptin and the regulation of endothelial function in physiological and pathological conditions

Clinical and Experimental Pharmacology and Physiology

Volumn 39, Issue 2, 2012, Pages 168-178

  Bełtowski, Jerzy ^a  

^a MEDICAL UNIVERSITY OF LUBLIN   (Poland)

Author keywords

Arterial hypertension; Atherosclerosis; Endothelial dysfunction; Endothelium derived hyperpolarizing factor; Leptin; Leptin resistance; Metabolic syndrome; Nitric oxide; Obesity

Indexed keywords

C REACTIVE PROTEIN; ENDOTHELIAL NITRIC OXIDE SYNTHASE; ENDOTHELIUM DERIVED HYPERPOLARIZING FACTOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; INSULIN; LEPTIN; NITRIC OXIDE; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; SUPPRESSOR OF CYTOKINE SIGNALING;

ADIPOSE TISSUE; ADRENERGIC SYSTEM; ARTICLE; CELL FUNCTION; DOWN REGULATION; ENDOTHELIAL DYSFUNCTION; ENDOTHELIUM CELL; HEALTH; HEMODYNAMIC MONITORING; HUMAN; HYPERLEPTINEMIA; INSULIN RESISTANCE; METABOLIC SYNDROME X; NONHUMAN; OBESITY; OXIDATIVE STRESS; PROTEIN PHOSPHORYLATION; VASCULAR ENDOTHELIUM; VASCULAR RESISTANCE; VASODILATATION;

ANIMALS; BLOOD PRESSURE; ENDOTHELIUM, VASCULAR; HUMANS; HYPERTENSION; LEPTIN; METABOLIC SYNDROME X; OBESITY; VASODILATION;

EID: 84856468453     PISSN: 03051870     EISSN: 14401681     Source Type: Journal    
DOI: 10.1111/j.1440-1681.2011.05623.x     Document Type: Article

References (77)

1. Barton M Obesity and aging. Determinants of endothelial cell dysfunction and atherosclerosis. Pflügers Arch. 2010; 460: 825-37.
2. Maenhaut N, Van de Voorde J. Regulation of vascular tone by adipocytes. BMC Med. 2011; 9: 25.
3. Achike FI, To NH, Wang H, Kwan CY. Obesity, metabolic syndrome, adipocytes and vascular function: A holistic viewpoint. Clin. Exp. Pharmacol. Physiol. 2011; 38: 1-10.
4. Hall JE, da Silva AA, do Carmo JMet al.Obesity-induced hypertension: Role of sympathetic nervous system, leptin, and melanocortins. J. Biol. Chem. 2010; 285: 17271-6.
5. Yiannikouris F, Gupte M, Putnam K, Cassis L. Adipokines and blood pressure control. Curr. Opin. Nephrol. Hypertens. 2010; 19: 195-200.
6. Sweeney G Cardiovascular effects of leptin. Nat. Rev. Cardiol. 2010; 7: 22-9.
7. Sattar N, Wannamethee G, Sarwar Net al.Leptin and coronary heart disease: Prospective study and systematic review. J. Am. Coll. Cardiol. 2009; 53: 167-75.
8. Gao Y The multiple actions of NO. Pflügers Arch. 2010; 459: 829-39.
9. Shimokawa H, Tsutsui M. Nitric oxide synthases in the pathogenesis of cardiovascular disease: Lessons from genetically modified mice. Pflügers Arch. 2010; 459: 959-67.
10. Vanhoutte PM, Shimokawa H, Tang EH, Feletou M. Endothelial dysfunction and vascular disease. Acta Physiol. 2009; 196: 193-222.
11. Oudit GY, Sun H, Kerfant BG, Crackower MA, Penninger JM, Backx PH. The role of phosphoinositide-3 kinase and PTEN in cardiovascular physiology and disease. J. Mol. Cell. Cardiol. 2004; 37: 449-71.
12. Edwards G, Félétou M, Weston AH. Endothelium-derived hyperpolarising factors and associated pathways: A synopsis. Pflügers Arch. 2010; 459: 863-79.
13. Félétou M, Vanhoutte PM. EDHF: An update. Clin. Sci. 2009; 117: 139-55.
14. Campbell WB, Fleming I. Epoxyeicosatrienoic acids and endothelium-dependent responses. Pflügers Arch. 2010; 459: 881-95.
15. Shimokawa H, Morikawa K. Hydrogen peroxide is an endothelium-derived hyperpolarizing factor in animals and humans. J. Mol. Cell. Cardiol. 2005; 39: 725-32.
16. Scotland RS, Madhani M, Chauhan Set al.Investigation of vascular responses in endothelial nitric oxide synthase/cyclooxygenase-1 double-knockout mice: Key role for endothelium-derived hyperpolarizing factor in the regulation of blood pressure in vivo. Circulation 2005; 111: 796-803.
17. Zhang Y, Proenca R, Maffei M, Barone M, Leopold L, Friedman JM. Positional cloning of the mouse obese gene and its human homologue. Nature 1994; 372: 425-32.
18. Myers MG, Cowley MA, Münzberg H. Mechanisms of leptin action and leptin resistance. Annu. Rev. Physiol. 2008; 70: 537-56.
19. Haynes WG, Morgan DA, Walsh SA, Mark AL, Sivitz WI. Receptor-mediated regional sympathetic nerve activation by leptin. J. Clin. Invest. 1997; 100: 270-8.
20. Dunbar JC, Hu Y, Lu H. Intracerebroventricular leptin increases lumbar and renal sympathetic nerve activity and blood pressure in normal rats. Diabetes 1997; 46: 2040-3.
21. Casto RM, VanNess JM, Overton JM. Effects of central leptin administration on blood pressure in normotensive rats. Neurosci. Lett. 1998; 246: 29-32.
22. Gardiner SM, Kemp PA, March JE, Bennett T. Regional haemodynamic effects of recombinant murine or human leptin in conscious rats. Br. J. Pharmacol. 2000; 130: 805-10.
23. Frühbeck G Pivotal role of nitric oxide in the control of blood pressure after leptin administration. Diabetes 1999; 48: 903-8.
24. Bełtowski J, Wójcicka G, Borkowska E. Human leptin stimulates systemic nitric oxide production in the rat. Obes. Res. 2002; 10: 939-46.
25. Bełtowski J, Jochem J, Wójcicka G, Zwirska-Korczala K. Influence of intravenously administered leptin on nitric oxide production, renal hemodynamics and renal function in the rat. Regul. Pept. 2004; 120: 59-67.
26. Lembo G, Vecchione C, Fratta Let al.Leptin induces direct vasodilation through distinct endothelial mechanisms. Diabetes 2000; 49: 293-7.
27. Kimura K, Tsuda K, Baba Aet al.Involvement of nitric oxide in endothelium-dependent arterial relaxation by leptin. Biochem. Biophys. Res. Commun. 2000; 273: 745-9.
28. ob) mice. J. Appl. Physiol. 2000; 89: 2382-90.
29. Belin de Chantemèle EJ, Mintz JD, Rainey WE, Stepp DW. Impact of leptin-mediated sympatho-activation on cardiovascular function in obese mice. Hypertension 2011; 58: 271-9.
30. Vecchione C, Maffei A, Colella Set al.Leptin effect on endothelial nitric oxide is mediated through Akt-endothelial nitric oxide synthase phosphorylation pathway. Diabetes 2002; 51: 168-73.
31. Mitchell JL, Morgan DA, Correia ML, Mark AL, Sivitz WI, Haynes WG. Does leptin stimulate nitric oxide to oppose the effects of sympathetic activation?Hypertension 2001; 38: 1081-6.
32. Yu Q, Gao F, Ma XL. Insulin says NO to cardiovascular disease. Cardiovasc. Res. 2011; 89: 516-24.
33. Niswender KD, Gallis B, Blevins JE, Corson MA, Schwartz MW, Baskin DG. Immunocytochemical detection of phosphatidylinositol 3-kinase activation by insulin and leptin. J. Histochem. Cytochem. 2003; 51: 275-83.
34. Vecchione C, Aretini A, Maffei Aet al.Cooperation between insulin and leptin in the modulation of vascular tone. Hypertension 2003; 42: 166-70.
35. Bełtowski J, Wójcicka G, Jamroz-Wiśniewska A, Borkowska E. Role of PI3K and PKB/Akt in acute natriuretic and NO-mimetic effects of leptin. Regul. Pept. 2007; 140: 168-77.
36. Procopio C, Andreozzi F, Laratta Eet al.Leptin-stimulated endothelial nitric-oxide synthase via an adenosine 5′-monophosphate-activated protein kinase/Akt signaling pathway is attenuated by interaction with C-reactive protein. Endocrinology 2009; 150: 3584-93.
37. Fisslthaler B, Fleming I. Activation and signaling by the AMP-activated protein kinase in endothelial cells. Circ. Res. 2009; 105: 114-27.
38. Mark AL, Shaffer RA, Correia ML, Morgan DA, Sigmund CD, Haynes WG. Contrasting blood pressure effects of obesity in leptin-deficient ob/ob mice and agouti yellow obese mice. J. Hypertens. 1999; 17: 1949-53.
39. Rahmouni K, Haynes WG, Morgan DA, Mark AL. Selective resistance to central neural administration of leptin in agouti obese mice. Hypertension 2002; 39: 486-90.
40. Rahmouni K, Morgan DA, Morgan GM, Mark AL, Haynes WG. Role of selective leptin resistance in diet-induced obesity hypertension. Diabetes 2005; 54: 2012-18.
41. Bełtowski J, Wójcicka G, Jamroz A. Stimulatory effect of leptin on nitric oxide production is impaired in dietary-induced obesity. Obes. Res. 2003; 11: 1571-80.
42. Bełtowski J, Wójcicka G, Jamroz-Wiśniewska A. Role of nitric oxide and endothelium-derived hyperpolarizing factor (EDHF) in the regulation of blood pressure by leptin in lean and obese rats. Life Sci. 2006; 79: 63-71.
43. Bełtowski J, Wójcicka G, Jamroz-Wiśniewska A, Marciniak A. Resistance to acute NO-mimetic and EDHF-mimetic effects of leptin in the metabolic syndrome. Life Sci. 2009; 85: 557-67.
44. Scarpace PJ, Zhang Y. Leptin resistance: A prediposing factor for diet-induced obesity. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2009; 296: R493-500.
45. Knight ZA, Hannan KS, Greenberg ML, Friedman JM. Hyperleptinemia is required for the development of leptin resistance. PLoS One 2010; 5: E11376.
46. Jaffar MM, Myers DS, Hainsworth LJ, Hainsworth R, Drinkhill MJ. Effects of dietary salt loading on the responses of isolated rat mesenteric arteries to leptin. Am. J. Hypertens. 2005; 18: 500-3.
47. Rodríguez A, Frühbeck G, Gómez-Ambrosi Jet al.The inhibitory effect of leptin on angiotensin II-induced vasoconstriction is blunted in spontaneously hypertensive rats. J. Hypertens. 2006; 24: 1589-97.
48. Wold LE, Relling DP, Duan J, Norby FL, Ren J. Abrogated leptin-induced cardiac contractile response in ventricular myocytes under spontaneous hypertension. Role of Jak/STAT pathway. Hypertension 2002; 39: 69-74.
49. Fonseca-Alaniz MH, Brito LC, Borges-Silva CN, Takada J, Andreotti S, Lima FB. High dietary sodium intake increases white adipose tissue mass and plasma leptin in rats. Obesity 2007; 15: 2200-8.
50. Myers MG, Leibel RL, Seeley RJ, Schwartz MW. Obesity and leptin resistance: Distinguishing cause from effect. Trends Endocrinol. Metab. 2010; 21: 643-51.
51. Coatmellec-Taglioni G, Dausse JP, Giudicelli Y, Ribière C. Sexual dimorphism in cafeteria diet-induced hypertension is associated with gender-related difference in renal leptin receptor down-regulation. J. Pharmacol. Exp. Ther. 2003; 305: 362-7.
52. Gu JW, Wang J, Stockton A, Lokitz B, Henegar L, Hall JE. Cytokine gene expression profiles in kidney medulla and cortex of obese hypertensive dogs. Kidney Int. 2004; 66: 713-21.
53. Bohlen F, Kratzsch J, Mueller Met al.Leptin inhibits cell growth of human vascular smooth muscle cells. Vascul. Pharmacol. 2007; 46: 67-71.
54. Vilà L, Roglans N, Alegret M, Sánchez RM, Vázquez-Carrera M, Laguna JC. Suppressor of cytokine signaling-3 (SOCS-3) and a deficit of serine/threonine (Ser/Thr) phosphoproteins involved in leptin transduction mediate the effect of fructose on rat liver lipid metabolism. Hepatology 2008; 48: 1506-16.
55. Gu H, Liu L, Ma Set al.Inhibition of SOCS-3 in adipocytes of rats with diet-induced obesity increases leptin-mediated fatty acid oxidation. Endocrine 2009; 36: 546-54.
56. Blanquicett C, Graves A, Kleinhenz DJ, Hart CM. Attenuation of signaling and nitric oxide production following prolonged leptin exposure in human aortic endothelial cells. J. Invest. Med. 2007; 55: 368-77.
57. Chen K, Li F, Li Jet al.Induction of leptin resistance through direct interaction of C-reactive protein with leptin. Nat. Med. 2006; 12: 425-32.
58. De Rosa S, Cirillo P, Pacileo M, Di Palma V, Paglia A, Chiariello M. Leptin stimulated C-reactive protein production by human coronary artery endothelial cells. J. Vasc. Res. 2009; 46: 609-17.
59. Gertler A, Niv-Spector L, Reicher S. Is leptin an important physiological regulator of CRP?Nat. Med. 2007; 13: 18-19.
60. Tanigaki K, Mineo C, Yuhanna ISet al.C-Reactive protein inhibits insulin activation of endothelial nitric oxide synthase via the immunoreceptor tyrosine-based inhibition motif of FcγRIIB and SHIP-1. Circ. Res. 2009; 104: 1275-82.
61. Beltowski J, Wójcicka G, Jamroz-Wiśniewska A, Borkowska E, Marciniak A. Antioxidant treatment normalizes nitric oxide production, renal sodium handling and blood pressure in experimental hyperleptinemia. Life Sci. 2005; 77: 1855-68.
62. Korda M, Kubant R, Patton S, Malinski T. Leptin induced endothelial dysfunction in obesity. Am. J. Physiol. Heart Circ. Physiol. 2008; 295: H1514-21.
63. Bełtowski J, Wójcicka G, Jamroz-Wiśniewska A, Wojtak A. Chronic hyperleptinemia induces resistance to acute natriuretic and NO-mimetic effects of leptin. Peptides 2010; 31: 155-63.
64. Xiang L, Dearman J, Abram SR, Carter C, Hester RL. Insulin resistance and impaired functional vasodilation in obese Zucker rats. Am. J. Physiol. Heart Circ. Physiol. 2008; 294: H1658-66.
65. Knudson JD, Dincer UD, Dick GMet al.Leptin resistance extends to the coronary vasculature in prediabetic dogs and provides a protective adaptation against endothelial dysfunction. Am. J. Physiol. Heart Circ. Physiol. 2005; 289: H1038-46.
66. Gual P, Le Marchand-Brustel Y, Tanti JF. Positive and negative regulation of insulin signaling through IRS-1 phosphorylation. Biochimie 2005; 87: 99-109.
67. Sahin AS, Bariskaner H. The mechanisms of vasorelaxant effect of leptin on isolated rabbit aorta. Fundam. Clin. Pharmacol. 2007; 21: 595-600.
68. Matsuda K, Teragawa H, Fukuda Y, Nakagawa K, Higashi Y, Chayana K. Leptin causes nitric-oxide independent coronary artery vasodilation in humans. Hypertens. Res. 2003; 26: 147-52.
69. Nakagawa K, Higashi Y, Sasaki S, Oshima T, Matsuura H, Chayana K. Leptin causes vasodilation in humans. Hypertens. Res. 2002; 25: 161-5.
70. Haddock RE, Grayson TH, Morris MJ, Howitt L, Chadha PS, Sandow SL. Diet-induced obesity impairs endothelium-derived hyperpolarization via altered potassium channel signaling mechanisms. PLoS One 2011; 6: E16423.
71. Chadha PS, Haddock RE, Howitt Let al.Obesity up-regulates intermediate conductance calcium-activated potassium channels and myoendothelial gap junctions to maintain endothelial vasodilator function. J. Pharmacol. Exp. Ther. 2010; 335: 284-93.
72. Katakam PV, Ujhelyi MR, Miller AW. EDHF-mediated relaxation is impaired in fructose-fed rats. J. Cardiovasc. Pharmacol. 1999; 34: 461-7.
73. Miller AW, Katakam PV, Ujhelyi MR. Impaired endothelium-mediated relaxation in coronary arteries from insulin-resistant rats. J. Vasc. Res. 1999; 36: 385-92.
74. Fortuno A, Rodriguez A, Gomez-Ambrosi Jet al.Leptin inhibits angiotensin II-induced intracellular calcium increase and vasoconstriction in the rat aorta. Endocrinology 2002; 143: 3555-60.
75. Rodríguez A, Fortuno A, Gómez-Ambrosi J, Zalba G, Diez J, Frühbeck G. The inhibitory effect of leptin on angiotensin II-induced vasoconstriction in vascular smooth muscle cells is mediated via a nitric oxide-dependent mechanism. Endocrinology 2007; 148: 324-31.
76. Rodríguez A, Gómez-Ambrosi J, Catalán V, Fortuño A, Frühbeck G. Leptin inhibits the proliferation of vascular smooth muscle cells induced by angiotensin II through nitric oxide-dependent mechanisms. Mediators Inflamm. 2010; 2010: 105489.
77. Momin AU, Melikian N, Shah AMet al.Leptin is an endothelial-independent vasodilator in humans with coronary artery disease: Evidence for tissue specificity of leptin resistance. Eur. Heart J. 2006; 27: 2294-9.